NECTRANT

US trademark, USPTO serial 99851200

"NECTRANT" is a registered US trademark filing (serial 99851200), owned by Glaxo Group Limited, filed May 28, 2026.

Get an email when this status changes

We email you about office actions, publication and registration for free, and we check after each USPTO data update.

Sign in to watch

Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.

Filing details

StatusRegistered
Serial number99851200
Filing dateMay 28, 2026
OwnerGlaxo Group Limited (243 filings)
NICE classes Class 5

Goods and services

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

Is "NECTRANT" available to trademark? →

Source and method

Built from public USPTO trademark records via WikiTrademarks. We match by exact wording, whole-word, phonetic sound-alike, and fuzzy look-alike, scoped by NICE class. Data reflects the most recent USPTO import. Last updated November 19, 2026.

Cite this page: WikiTrademarks, "NECTRANT trademark (serial 99851200)", https://wikitrademarks.com/trademark/99851200/nectrant (accessed November 19, 2026).